Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Chlamydia Trachomatis | Research article

Prevalence and factors associated with trichomonas vaginalis infection among female sex workers in Togo, 2017

Authors: Martin Kouame TCHANKONI, Alexandra Marie Bitty-Anderson, Arnold Junior SADIO, Fifonsi Adjidossi GBEASOR-KOMLANVI, Valentine Marie FERRÉ, Wendpouiré Ida Carine ZIDA-COMPAORE, Ameyo Monique DORKENOO, Bayaki SAKA, Anoumou Claver DAGNRA, Charlotte CHARPENTIER, Didier Koumavi EKOUEVI

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

The aim of this study was to estimate the prevalence and factors associated with Trichomonas vaginalis (T. vaginalis) among female sex workers (FSW) in Togo in 2017. A cross-sectional bio-behavioral study was conducted from August to October 2017 using a respondent-driven sampling method in four cities in Togo.

Method

A standardized questionnaire was used to record socio-demographic data and sexual behavior patterns. T. vaginalis detection by molecular biology tests was performed using Allplex STI Essential Assay which detect also 6 others micro-organisms. A blood sample was drawn and serological test using SD Bioline Duo VIH/Syphilis rapid test was performed for Human immunodeficiency virus (HIV) and syphilis testing.

Results

A total of 310 FSW with median age 25 years, interquartile range (IQR) [21–32 years] were included. The prevalence of T. vaginalis was 6.5% (95%CI = [4.1–9.9]) and, overall, prevalence of other STI ranged from 4.2% (95%CI = [2.3–7.2]) for N. gonorrhoeae to 10.6% (95% CI = [7.5–14.7]) for HIV. Binary logistic regression was conducted to assess factors associated with T. vaginalis infection. Living in Lomé (aOR = 3.19; 95%CI = [1.11–11.49]), having had sexual intercourse before the age of 18 (aOR = 5.72; 95%CI = [1.13–10.89]), and being infected with C. trachomatis (aOR = 3.74; 95%CI = [2.95–12.25]) were factors associated with T. vaginalis among FSW.

Conclusion

The prevalence of T. vaginalis infection using molecular test was low among FSW in Togo. Extensive studies are needed to confirm and to better understand the epidemiology of T. vaginalis among this population and in other populations in Togo.
Literature
4.
go back to reference World Health Organization (WHO), Department of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: WHO; 2012, 20p. World Health Organization (WHO), Department of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: WHO; 2012, 20p.
8.
go back to reference Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007;44(1):13–22. https://doi.org/10.1086/511144. Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007;44(1):13–22. https://​doi.​org/​10.​1086/​511144.​  
13.
go back to reference Serwin AB, Koper M. Trichomoniasis–an important cofactor of human immunodeficiency virus infection. Przegl Epidemiol. 2013;67:47–50.PubMed Serwin AB, Koper M. Trichomoniasis–an important cofactor of human immunodeficiency virus infection. Przegl Epidemiol. 2013;67:47–50.PubMed
15.
go back to reference Donbraye E, Donbraye-Emmanuel OOB, Okonko IO, Okedeji IO, Alli JA, Nwanze JC. Detection and prevalence of trichomonas vaginalis among pregnant women in Ibadan, Southwestern Nigeria. World Appl Sci J. 2010;11:1512–7. Donbraye E, Donbraye-Emmanuel OOB, Okonko IO, Okedeji IO, Alli JA, Nwanze JC. Detection and prevalence of trichomonas vaginalis among pregnant women in Ibadan, Southwestern Nigeria. World Appl Sci J. 2010;11:1512–7.
16.
go back to reference Preethi V, Mandal J, Halder A, Parija SC. Trichomoniasis: an update. Trop Parasitol. 2011;1:73.CrossRef Preethi V, Mandal J, Halder A, Parija SC. Trichomoniasis: an update. Trop Parasitol. 2011;1:73.CrossRef
17.
go back to reference Ijasan O, Okunade KS, Oluwole AA. The prevalence and risk factors for Trichomonas vaginalis infection among HIV-infected pregnant women attending the antenatal clinics of a university teaching hospital in Lagos, South-western, Nigeria. Niger Postgrad Med J. 2018;25:21.CrossRef Ijasan O, Okunade KS, Oluwole AA. The prevalence and risk factors for Trichomonas vaginalis infection among HIV-infected pregnant women attending the antenatal clinics of a university teaching hospital in Lagos, South-western, Nigeria. Niger Postgrad Med J. 2018;25:21.CrossRef
18.
go back to reference Ferré VM, Ekouevi DK, Gbeasor-Komlanvi FA, Collin G, Le Hingrat Q, Tchounga B, et al. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2019;25:1560.e1–7. Ferré VM, Ekouevi DK, Gbeasor-Komlanvi FA, Collin G, Le Hingrat Q, Tchounga B, et al. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2019;25:1560.e1–7.
28.
go back to reference Tchelougou D, Karou DS, Kpotsra A, Balaka A, Assih M, Bamoke M, et al. Infections vaginales chez les femmes enceintes au centre hospitalier régional de Sokodé (Togo) entre 2010 et 2011. Médecine Santé Trop. 2013;23:49–54.CrossRef Tchelougou D, Karou DS, Kpotsra A, Balaka A, Assih M, Bamoke M, et al. Infections vaginales chez les femmes enceintes au centre hospitalier régional de Sokodé (Togo) entre 2010 et 2011. Médecine Santé Trop. 2013;23:49–54.CrossRef
35.
go back to reference Masha SC, Cools P, Descheemaeker P, Reynders M, Sanders EJ, Vaneechoutte M. Urogenital pathogens, associated with trichomonas vaginalis, among pregnant women in Kilifi, Kenya: a nested case-control study. BMC Infect Dis. 2018;18:1–7. Masha SC, Cools P, Descheemaeker P, Reynders M, Sanders EJ, Vaneechoutte M. Urogenital pathogens, associated with trichomonas vaginalis, among pregnant women in Kilifi, Kenya: a nested case-control study. BMC Infect Dis. 2018;18:1–7.
37.
go back to reference Joseph Davey DL, Nyemba DC, Gomba Y, Bekker LG, Taleghani S, DiTullio DJ, Shabsovich D, Gorbach PM, Coates TJ, Klausner JD, Myer L. Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa. PLoS One. 2019;14(7):e0218349. https://doi.org/10.1371/journal.pone.0218349. Joseph Davey DL, Nyemba DC, Gomba Y, Bekker LG, Taleghani S, DiTullio DJ, Shabsovich D, Gorbach PM, Coates TJ, Klausner JD, Myer L. Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa. PLoS One. 2019;14(7):e0218349. https://​doi.​org/​10.​1371/​journal.​pone.​0218349.
Metadata
Title
Prevalence and factors associated with trichomonas vaginalis infection among female sex workers in Togo, 2017
Authors
Martin Kouame TCHANKONI
Alexandra Marie Bitty-Anderson
Arnold Junior SADIO
Fifonsi Adjidossi GBEASOR-KOMLANVI
Valentine Marie FERRÉ
Wendpouiré Ida Carine ZIDA-COMPAORE
Ameyo Monique DORKENOO
Bayaki SAKA
Anoumou Claver DAGNRA
Charlotte CHARPENTIER
Didier Koumavi EKOUEVI
Publication date
01-12-2021

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.